echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Metabolomics research reveals signs of autism.

    Metabolomics research reveals signs of autism.

    • Last Update: 2020-07-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , March 20, 2020 /PRNewswire/ --- In a paper published this week in the journal Autism Research, researchers at the University of California, Davis and others report new findings on childhood autismblood sample analysis from CAMP is the largest study to date on the metabolism of children with autism spectrum disorder (ASD), which analyzed the unique metabolic characteristics of more than 50 percent of children with autism, known as metabolic typesThis is an important step towards setting the goal of establishing a set of metabolomic tests that could lay the foundation for biological screening of the risks of ASD"Using a metabolomic method to detect objective biomarkers of ASD is a promising approach because the interaction between metabolites to the genome, gastrointestinal microbiome, diet and all environmental factors increases the risk of autism," said DrRobert Burrier, chief operating officer of Stemina,author of the(picture:The "
    " CAMP study is a pioneering study of the metabolism of autistic childrenThe study was carefully designed to identify and verify typical metabolic differences between children with ASD and normal child populations," said the authors of the study, drElizabeth DonleyDrAmaral said: "There are currently no effective biomarkers to detect autism risk in young children, and we are optimistic about this approach, which has the potential to detect the risk of childhood disease as early as possibleIn addition, this approach provides new targeted and personalized therapiesThese questions need to be further tested in CAMP studiesDonley added: "The new findings from the CAMP study represent advances in our efforts to develop metabolomics-based ASD screening tools, and while there are no signs of definitive diagnosis of ASD, combining metabolomics-based screening with behavioral testing can increase the likelihood of early detection of people at risk of ASD." " (Bio Valley Bioon.com)source: A metabolomics approach to detect objective biomarkers of ASD original origin: a metabolomics for screening for autism risk in the children's autismemememe.project.
    Autism Research, 2020: doi: 10.1002/aur.2330
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.